Corrigendum to 'Balasubramide derivative 3C modulates microglia activation via CaMKKβ-dependent AMPK/PGC-1α pathway in neuroinflammatory conditions' [Brain Behav. Immun. 67 (2018) 101-117]

Affiliations

• ¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, PR China.
• ² College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
• ³ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China.
• ⁴ Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20057, USA.
• ⁵ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, PR China; College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.
• ⁶ College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address: linhansenyd@163.com.
• ⁷ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Screening, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20057, USA. Electronic address: tpang@cpu.edu.cn.